Literature DB >> 18385695

Drug markers questioned.

Heidi Ledford.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18385695     DOI: 10.1038/452510a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Off-tumor target--beneficial site for antiangiogenic cancer therapy?

Authors:  Yihai Cao
Journal:  Nat Rev Clin Oncol       Date:  2010-08-03       Impact factor: 66.675

2.  Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity.

Authors:  Danfang Zhang; Eva-Maria E Hedlund; Sharon Lim; Fang Chen; Yin Zhang; Baocun Sun; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-18       Impact factor: 11.205

3.  Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome.

Authors:  Yuan Xue; Piotr Religa; Renhai Cao; Anker Jon Hansen; Franco Lucchini; Bernt Jones; Yan Wu; Zhenping Zhu; Bronislaw Pytowski; Yuxiang Liang; Weide Zhong; Paolo Vezzoni; Björn Rozell; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

4.  Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship.

Authors:  John M McPartland
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

5.  Tumor-derived VEGF modulates hematopoiesis.

Authors:  Yuan Xue; Fang Chen; Danfang Zhang; Sharon Lim; Yihai Cao
Journal:  J Angiogenes Res       Date:  2009-12-23

6.  Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage.

Authors:  Adriano B Nogueira; Ariel B Nogueira; José C Esteves Veiga; Manoel J Teixeira
Journal:  Neurosurgery       Date:  2014-12       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.